- Home
- POAI vs SACH Comparison
POAI vs SACH Comparison
Compare POAI & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- SACH
- Stock Information
- Founded
- POAI 2002
- SACH 2010
- Country
- POAI United States
- SACH United States
- Employees
- POAI 35
- SACH N/A
- Industry
- POAI Industrial Specialties
- SACH Real Estate Investment Trusts
- Sector
- POAI Health Care
- SACH Real Estate
- Exchange
- POAI Nasdaq
- SACH Nasdaq
- Market Cap
- POAI 9.9M
- SACH N/A
- IPO Year
- POAI N/A
- SACH 2017
- Fundamental
- Price
- POAI $1.30
- SACH $1.02
- Analyst Decision
- POAI Hold
- SACH Hold
- Analyst Count
- POAI 1
- SACH 3
- Target Price
- POAI N/A
- SACH $2.25
- AVG Volume (30 Days)
- POAI 8.1M
- SACH 388.9K
- Earning Date
- POAI 05-13-2025
- SACH 05-09-2025
- Dividend Yield
- POAI N/A
- SACH 17.48%
- EPS Growth
- POAI N/A
- SACH N/A
- EPS
- POAI N/A
- SACH N/A
- Revenue
- POAI $1,623,817.00
- SACH N/A
- Revenue This Year
- POAI $486.27
- SACH N/A
- Revenue Next Year
- POAI $65.50
- SACH N/A
- P/E Ratio
- POAI N/A
- SACH N/A
- Revenue Growth
- POAI N/A
- SACH N/A
- 52 Week Low
- POAI $0.55
- SACH $1.00
- 52 Week High
- POAI $3.06
- SACH $3.75
- Technical
- Relative Strength Index (RSI)
- POAI 48.03
- SACH 39.44
- Support Level
- POAI $1.26
- SACH $1.02
- Resistance Level
- POAI $1.58
- SACH $1.19
- Average True Range (ATR)
- POAI 0.21
- SACH 0.06
- MACD
- POAI 0.01
- SACH -0.02
- Stochastic Oscillator
- POAI 16.13
- SACH 2.44
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.